Our European Pharmaceutical Pricing & Reimbursement conference will be held on 13 & 14 October. Now in its 20th year, this event has been one of the oldest market leaders in the pharmaceutical industries calendar for some time.

Our expert speaking faculty; made up from key industry personnel from big pharma, biotech and academia will thoroughly explain and offer advice on P&R and market access. The 2014 agenda will focus on case studies as applied to different countries and environments in terms of market access.

  • Evaluate challenges within price discrimination
  • Implications of AMNOG featuring IGES Institut,
    EUCOPE and Ministry of Health, Germany
  • Case study from Ipsen on latest developments
    in pharmaceutical pricing
  • Analyse the impact of Value Based Assessment
    on SMEs
  • Gain further insight on how to engage
    effectively with payers
  • Key presentation on the IMI GetReal consortium

• Market Access
• Launch Excellence
• Pricing and Reimbursement
• Marketing (Consumer, Relationship, Multi channel,Strategic)
• Project Management
• Value Based Pricing
• Business Development
• Patient Advocacy
• Medical Information & Education
• Business Analysis
• eMarketing
• Pharmacy Operations
• Specialty and Orphan drugs market
• Patient communications
• Health economics and outcomes research
• External affairs

Alexion Pharmaceuticals Inc; Astellas Pharma Europe Ltd; AstraZeneca; Bristol Myers Squibb; Catenion; Celegene Corporation; Eli Lilly & Co; Eli Lilly & Company; Ethical Medicines Industry Group; GlaxoSmithKline plc; Grifols Deutschland; GSK; IGES Institut.; Imperial College London; IMS Health; Ipsen Ltd; Janssen-Cilag Pharmaceutical S A C I; Justpharmareports; Novo Nordisk Pharmaceuticals Ltd; Pfizer Limited Chemical Div; Pharmaceutical Works POLPHARMA SA; Quintiles (UK) Ltd; Quintiles Ltd; Roche; Swansea University; Teva Pharmaceuticals Europe BV; Teva UK; TEVA UK Limited; White & Case LLP;

Conference programme

9:30 Registration and Coffee

10:00 Chairman's opening remarks

Peter Hertzman

Peter Hertzman, Independent Health Access Consultant, Zurich

10:10 Price discrimination - gaining an overview


  •  What does price discrimination mean and why is it relevant?
  • Evaluating challenges and obstacles for price discrimination
  • How are differences in HTA approaches between countries influencing price discrimination?
  • Various options to achieve price discrimination, including outcome based contracts
  • Peter Hertzman

    Peter Hertzman, Independent Health Access Consultant, Zurich

    10:50 Price Optimisation from Launch Onwards

    James Robinson

    James Robinson, Director of Industry Solutions, Model N, Inc.

  • How changes in the P&R landscape are impacting launch strategies
  •  Insights from the Model N 2014 Benchmark Survey
  • The new imperatives for agile launch planning
  • Managing in-market price erosion in primary markets to profit through the long tail
  • 11:30 Morning Coffee

    12:00 AMNOG and Early Benefit Assessment - Situation and Trends

    Bertram Häussler

    Bertram Häussler, Director, IGES Institut.


  • 3 years of AMNOG and EBA – lessons learned
  • Implications of the first modification law (effective April 1, 2014)
  • Moving forward
  • Case study of system in action
  • 12:40 Value Based Assessment

    Leslie Galloway

    Leslie Galloway, Chairman, Ethical Medicines Industry Group


  • What difference will it make?
  • Issues for the pharmaceutical industry
  • Issues for SMEs
  • 13:20 Networking Lunch

    14:30 Engagement with payers - how to successfully engage with payers and be heard

    Leyla Hannbeck

    Leyla Hannbeck, Head of Pharmacy Services, National Pharmacy Association

    15:10 From value based pricing to value based buying

    Janice Haigh

    Janice Haigh, Practice Leader, Market Access, Quintiles (UK) Ltd


  • How to support health systems in making the right value based decisions
  • Making the transition from product value to value delivered in the real environment
  • How can the industry engage with local payers and deliver value
  • Supporting value based decisions by demonstrating measurable results of new drugs


  • 15:50 Afternoon Tea

    16:20 AMNOG and its international implications

    Alexander Natz

    Alexander Natz, Director, EUCOPE

    17:00 Chairman's Closing Remarks and Close of Day One

    Peter Hertzman

    Peter Hertzman, Independent Health Access Consultant, Zurich

    17:10 Drinks Reception sponsored by Quintiles

    8:30 Registration and Coffee

    9:00 Chairs Opening Remarks

    Leslie Galloway

    Leslie Galloway, Chairman, Ethical Medicines Industry Group

    9:10 Generics in France

    Irma van den Arend

    Irma van den Arend, VP, Global Pricing, Reimbursement and Funding, Ipsen

    9:50 Case Study Presentation: Developing a Co-creation Model with Payers

    Francois Bernard

    Francois Bernard, Head Market Access, Mundipharma


  • Understand payer preferences on patient pathway optimization
  • Identify and develop solutions to co-create incremental value with external stakeholders including payers
  • Moving our customer market access model from a “push” to a “pull” approach
  • 10:30 Morning Coffee

    11:00 Is there room for real world data in medicine development?

    Mike  Chambers

    Mike Chambers, Director of Health Economics, GlaxoSmithKline


  • The emerging environment: conditional and adaptive processes for marketing authorisation and reimbursement
  • The use of ‘real world’ data in generating early estimates of relative effectiveness
  • The IMI GetReal consortium: towards a shared framework for decision making
  • 11:40 Japanese Pricing and Reimbursement after the 2014 Reforms

    Don Macarthur

    Don Macarthur, Global Pharmaceutical Business Analyst, DM Pharma Issues Ltd


  • Changes to launch pricing rules
  • Role of premium for new drug development
  • New measures for off-patent brands and generics
  • Whatever happened to demands for cost effectiveness?
  • 12:20 Networking Lunch

    13:30 The Future Scenario of P&R: health reforms and companies' strategies

    Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara


  • Demand and offer of pharmaceuticals as public health criticism
  • Actions by pharma agencies: NICE and others
  • Sustainability of innovation
  • Approaching new paradigms for companies
  • 14:10 A Dutch Approach to Reimbursement

    Linda  Van Saase

    Linda Van Saase, Manager, National Healthcare Institute


  • The impact of personalised medicine on Pricing and Reimbursement
  • Clarifying the conundrum of reimbursement authorities
  • The dutch solution – implementing boundaries for all stakeholders
  • Negotiating the best outcome for healthcare – illustrated with examples
  • 14:50 Panel Discussion - Managing International Challenges of HTA

    Janice Haigh

    Janice Haigh, Practice Leader, Market Access, Quintiles (UK) Ltd

    Francois Bernard

    Francois Bernard, Head Market Access, Mundipharma

    15:30 Chairs Closing Remarks and Afternoon Tea

    Leslie Galloway

    Leslie Galloway, Chairman, Ethical Medicines Industry Group


    Sponsors and Exhibitors


    Sponsors and Exhibitors

    Model N

    Sponsors and Exhibitors

    We help our clients profitably grow their businesses. Our services and relationships never take a “Cookie Cutter” Approach. You will always know you are our most important client. We offer a customized, client centric and competitively priced menu of management, product pricing, analytics and consulting services designed to suit your unique needs and budgetary constraints. From government pricing & contract management services, chargeback processing, rebate reconciliation and payment, rebate liability forecasting & complex business analytics to serving as your virtual sales operations administration department, we can offer a comprehensive turn-key package of services designed to support the needs of start-up pharmaceutical companies or a cafeteria-style offering for fully developed companies interested in empowering internal resources to focus on growing the business rather than dealing with the complexities of government or commercial contract management, compliance and administration.


    Sponsors and Exhibitors

    Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. We are positioned at the intersection of business services and healthcare, conduct business in approximately 100 countries and have more than 32,000 employees. We use the breadth and depth of our service offerings, our global footprint and our therapeutic, scientific and analytics expertise to help our biopharmaceutical customers, as well as other healthcare customers, navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.

    Media Partners



    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.

    Pharmaceutical Technology


    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.



    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

    Swiss Biotech Association


    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.

    The Pharma Letter


    The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.



    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.

    Life Science Global


    Lifescience Global aims to publish peer-reviewed research journals covering wide range of academic disciplines. Our aim is to maintain the highest standards of review through internationally-recognized editorial teams. In addition, we also provide publishing and e-marketing services to Universities, Conferences and Research Institutions for their niche scholarly market requirements.



    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.

    Journal of Pharmaceutical Health Care and Sciences (JPHCS)


    Journal of Pharmaceutical Health Care and Sciences (JPHCS) is an open access, peer-reviewed online journal that encompasses all aspects of clinical pharmacy as well as clinical and experimental pharmacotherapy. JPHCS welcomes submissions from all fields of pharmaceutical health care and sciences.

    BioMed Central


    BioMed Central is an online STM publisher of more than 270 peer-reviewed open access journals. The portfolio of journals spans all areas of biology, biomedicine and medicine, with many journals publishing content related to pulmonary medicine and allergy research. Examples of such journals include: COPD Research and Practice, Multidisciplinary Respiratory Medicine, Respiratory Research, and Allergy, Asthma & Clinical Immunology. All original research articles published by BioMed Central are made freely accessible online immediately upon publication. Authors publishing with BioMed Central retain copyright of their work, licensing it under the Creative Commons Attribution License which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited. BioMed Central is owned by Springer Science+Business Media, and also hosts the SpringerOpen platform.

    Drug Discovery World


    For over a decade DDW has continued to be the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms.



    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.

    Cutting Edge


    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.



    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/



    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….

    Thomson Reuters


    Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.



    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com



    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.

    Select Science


    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.

    Pharma Marketing News


    Pharma Marketing News is an independent monthly electronic newsletter focused on issues of importance to pharmaceutical marketing executives. It is a service of the Pharma Marketing Network -- The First Forum for Pharmaceutical Marketing Experts -- which brings together pharmaceutical marketing professionals from manufacturers, communications companies, and marketing service providers for wide ranging discussions and education on a multitude of current topics. Pharma Marketing Network & Pharma Marketing News provide executive-level content coupled with permission-based e-marketing opportunities.



    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.



    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.

    Journal of Pharmaceutical Policy and Practice


    Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review) is an open access, peer-reviewed journal. It provides a platform for researchers to disseminate empirical research findings, with the aim that people everywhere have access to the medicines they need and use them rationally.

    KONGPOSH Publications


    KONGPOSH Publications is one of India’s leading Pharma Publishers. The Pharma Review® is a bi-monthly article based journal covering various fields of pharmacy. Participation and distribution in over 30 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. Also available in E-book format. Other publications : Indian Pharma Reference Guide (Annual) – Names and address of Pharmaceuticals, Bulk Drugs, Machinery’s & Instrumentation, AYUSH Manufacturers; and much more; High Performance Thin Layer Chromatography; Elements of Pharmacovigilance; Regulation of Clinical Trials; AYUSH (CD); NDDS/AMD (CD)



    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.

    Medical News Today


    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.

    Antibodies Online


    antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.

    Technology Networks


    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com



    A pioneer in the field, HealthEconomics.Com is the world’s most comprehensive and credible website for resources and jobs in healthcare value and market access. A trusted resource, HealthEconomics.Com contains the hottest news, jobs, policy updates, professional development, and education resources, and offers unparalleled advertising opportunities. As the #1 Google ranked website in health economics, HealthEconomics.Com attracts 11,000 visitors every month and the well-respected Newsletter reaches 20,000 professionals every week. The comprehensive content is carefully selected by a discerning health economist editor, making us the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.



    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!

    Venue To Be Confirmed

    United Kingdom

    Venue To Be Confirmed



    speaker image






    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title


    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event


    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71

    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SMi.
    Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out